Isochem brings revitalized portfolio to CPhI Madrid

Vert-Le-Petit, France: –Fine chemicals and active ingredients specialist CMO Isochem will field a strong suite of offers and opportunities when it attends CPhI Worldwide in Madrid in October.

In particular, Isochem will be able to present visitors to its stand C30 in Hall 5 at Madrid’s IFEMA expo centre with newly developed offers on for development projects, made possible by ramping up its teams and capabilities in R&D and project management.

The year since CPhI in Paris has seen significant changes at Isochem, which has enjoyed a year of strong growth and productivity gained from its strategy of refocusing on pharmaceutical business opportunities with the emphasis on custom synthesis.

Isochem has also expanded exports outside its native France, and has particularly raised its profile in North America.

Custom synthesis

Main growth drivers have been increased demand for Isochem’s custom synthesis products, along with the company’s catalog products, generic APIs and excipients.

“We will be able to show our visitors how our new focus on pharma has led to noticeable growth in sales turnover and renewed vigor in our manufacturing and product pipeline,” said Isochem VP of Sales and Business Development, Amélie Arboré.

“We are able to present a strong proposition of a fine chemical company that offers high-performing services from R&D to production in custom synthesis within a framework emphasizing responsive communication and transparency for maximum confidence,” said Ms. Arboré.

“Our capabilities now include full cGMP manufacturing, route selection, process and analytical development and process optimization from laboratory scale to full production, as well as delivery of safe implementation of hazardous reactions and versatile chemistry,” she added.

Ms. Arboré will be present at CPhI, along with leaders of Isochem’s R&D, Quality, Purchasing and Project Management teams.

About Isochem

Isochem S.A.S. is a contract manufacturer with a century-old heritage in fine chemistry and a 40-year track record in providing high quality fine chemicals, APIs and high added value molecules substances and mastering complex processes. The company can manufacture products and provide services to the most recent and stringent pharmaceutical regulatory standards.

Isochem serves a broad range of customers in many application fields, from leading global companies to virtual and emerging organizations, offering services in three pharma-related fields: custom synthesis, high technology manufacturing in multi-step chemical synthesis including the safe implementation of hazardous reactions, and direct supply of more than 2,300 specific compounds and products, including phosgene derivatives, regulated and non-regulated intermediates and active ingredients.

Isochem can also provide attractive synthetic tools such as activated aminoacids building blocks (N-CarboxyAnhydride NCA) used in peptide chemistry. It is also expert in process optimization from pre-clinical development to full-scale production.

Isochem is now an international company with some 350 employees worldwide. The Head office is located near Paris, in Vert-Le-Petit, France, on one of Isochem’s five manufacturing sites. The company is a wholly owned subsidiary of Munich-based Aurelius AG.

About CPhI 2015

CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitor opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends.

Now in its 26th year, the 2015 event is a three-day event opening October 13 at IFEMA, Feria de Madrid. Last year’s even in Paris attracted almost 36,500 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.

The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

The Pre-Connect Conference on October 12 brings together senior representatives and key stakeholders from all segments of the industry for a series of market-led educational modules on the latest trends and topics with networking and partnering opportunities.

The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders. The previous three categories (formulation, process development and packaging) have now been expanded to eight awards, now additionally honoring best innovations in biologic drug development and manufacturing, supply chain & logistic management, manufacturing technology, APIs and excipients, as well as CEO of the Year.

The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/home